Flavio G Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute, shared a post on X:
“Dr. Maheswari Senthil, UC Irvine Surgery discussing CRS+HIPEC abstracts for gastric cancer.
Takeaways and remaining?
IP therapy increases peritoneal disease control Surgery in select patients after treatment
Increased OS. ECOG-ACRIN Cancer Research Group EA2234 STOPGAP may answer.
Great to see SurgOnc leading trials in this space.”
